HeparDx is an emerging NASH/MASH and liver fibrosis blood test designed to diagnose patients earlier and monitor disease progression The data presentations add.
A novel liquid biopsy test, which uses two circulating proteins, appears to be effective for diagnosing these two major liver conditions, according to a new study.